Rare diseases
Investigational molecules
Locations
Back to the Netherlands97 clinical trials in Heerlen, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on 5-Fluorouracil and Calcipotriol for Treating Actinic Keratosis in Patients
The NetherlandsStudy on Semaglutide for Achieving Sinus Rhythm in Patients with Obesity and Persistent Atrial Fibrillation
The NetherlandsStudy on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer
The NetherlandsStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
The NetherlandsStudy on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)
The NetherlandsStudy on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma
The NetherlandsStudy on Progesterone for Improving Birth Rates in Couples with Unexplained Infertility Undergoing Mild Ovarian Stimulation and Intrauterine Insemination
The NetherlandsStudy Comparing Rituximab and Ocrelizumab for Patients with Relapsing Multiple Sclerosis Starting Anti-CD20 Therapy
The NetherlandsStudy on Reducing Bleeding by Omitting Aspirin in Patients with Non-ST Elevation Acute Coronary Syndrome
The NetherlandsStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
The NetherlandsStudy of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease
The NetherlandsStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on multiple sclerosis and stroke management, including trials evaluating new therapeutic approaches for both relapsing and progressive forms of MS.
Novel therapies being tested include frexalimab and tolebrutinib for multiple sclerosis patients.
Comprehensive studies in cancer treatment, with particular focus on lung cancer, melanoma, and prostate cancer therapies.
Innovative approaches including PSMA-PET/CT imaging and immunotherapy combinations are being evaluated.
Studies addressing cardiovascular diseases and related conditions, including innovative treatments for heart disease and stroke prevention.
Trials include pelacarsen for cardiovascular risk reduction and statin therapy evaluations.
Research into pulmonary conditions, particularly focusing on fibrotic lung diseases and their treatment approaches.
Including trials of inhaled treprostinil and nerandomilast for various forms of lung fibrosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
